Company: OncoResponse Inc.
Job title: CSO
Using the Human Immune System to Identify Antibodies That Modulate the Tumor Microenvironment 4:00 pm
Discovery of lead antibody OR2805 from a cancer elite responder that relieves the suppressive effects of M2 macrophages on T-cell function Demonstrates anti-tumor activity in cancer xenograft modelsRead more
day: Discovery & Pre-Clinical Development - Day 1 pm2
Industry Leader’s Fireside Chat 10:30 am
An executive panel discussion from the C-level leaders of the field to set the scene on macrophage directed therapy development. Ask your questions live to understand the expert’s thoughts on key topics including safety and toxicity management, controlling the plasticity of macrophages and exploring the immunological memory of macrophagesRead more
day: Day One